Cargando…
CD4 Count and Anti Retroviral Therapy for HIV Positive Patients With Cancer in Nigeria -A Pilot Study
BACKGROUND: Highly Active Anti Retroviral Treatment (HAART) improves the outcome of HIV positive patients treated for cancer. In our center HAART is only commenced in HIV positive patients with malignancy if the CD4 T lymphocyte count is less than 200 cells/ul. Presently, the outcome of treatment in...
Autores principales: | Ntekim, Atara I., Folasire, Ayo. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2918360/ https://www.ncbi.nlm.nih.gov/pubmed/20703325 |
Ejemplares similares
-
The Prevalence of Prostate Cancer Among Young Men Below 55 Years of
Age in Nigeria
por: Ntekim, Atara, et al.
Publicado: (2023) -
Pattern of survival of breast cancer patients in a tertiary hospital in South West Nigeria
por: Ali-Gombe, Musa, et al.
Publicado: (2021) -
Survival pattern of rare histological types of breast cancer in a Nigerian institution
por: Ntekim, Atara Isaiah, et al.
Publicado: (2019) -
Intestinal Parasitosis in Relation to Anti-Retroviral Therapy, CD4(+) T-cell Count and Diarrhea in HIV Patients
por: Khalil, Shehla, et al.
Publicado: (2015) -
Optimal management of cervical cancer in HIV-positive patients: a systematic review
por: Ntekim, Atara, et al.
Publicado: (2015)